Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
BMC Genomics|June 17, 2015
Sex and parasites: genomic and transcriptomic analysis of Microbotryum lychnidis-dioicae, the biotrophic and plant-castrating anther smut fungusMichael H Perlin, Joelle Amselem, Eric Fontanillas, et al.
Frontiers in Immunology|February 10, 2018
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic TargetMaliha Khan, Selena Carmona, Pariya Sukhumalchandra, et al.
Molecular Cell|February 14, 2026
BRD4-mediated ER membrane contact creates functionally distinct mitochondrial subtypesBrandon Chen, Drew C Stark, Pankaj V Jadhav, et al.
Nature Genetics|August 14, 2019
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancerSahar Nissim, Ignaty Leshchiner, Joseph D Mancias, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Nature Chemical Biology|April 7, 2020
Discovery of a selective inhibitor of doublecortin like kinase 1Fleur M Ferguson, Behnam Nabet, Srivatsan Raghavan, et al.
Journal of the National Cancer Institute|August 12, 2025
Stereotactic MRI Guided Adaptive Radiotherapy: a pooled analysis of a master prospective trialJonathan E Leeman, Kee-Young Shin, Alexander Droznin, et al.
Science (New York, N.Y.)|May 9, 2015
Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasionElizabeth S Egan, Rays H Y Jiang, Mischka A Moechtar, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerPatricia Rich, R Brian Mitchell, Eric Schaefer, et al.
Pageof 11